Loading...
Images of Bjoern Chapuy
(0 from 0 )1
0
0
News
News Releases - Dana-Farber Cancer Institute
www.dana-farber.org
5 Dec — Co-authors are Ann LaCasce, MD, Margaretha Roemer, Bjoern Chapuy, MD, PhD, Philippe Armand, MD, PhD, and Scott Rodig, MD, PhD, ... › ... › News Releases
El nivolumab aporta importante beneficio al linfoma de Hodgkin en...
newsnetwork.mayoclinic.org
El nivolumab aporta importante beneficio al linfoma de Hodgkin en fase I de estudio codirigido por Mayo Clinic
An Evolutionary Relic of the Genome Causes Cancer | BIDMC of Boston
www.bidmc.org
Scientists in the BIDMC Cancer Research Institute discover that a non-coding pseudogene leads to the development of a lymphoma-like cancer.
Nivolumab shows significant benefit for Hodgkin’s lymphoma in Mayo...
newsnetwork.mayoclinic.org
Nivolumab shows significant benefit for Hodgkin’s lymphoma in Mayo Clinic co-led phase I study
Telephone & Addresses
WhitePages: Bjoern Chapuy | 1 records found | Whitepages
View phone numbers, addresses, public records, background check reports and possible arrest records for Bjoern Chapuy. Whitepages people search is the ...
Physicians & MDs
PD-1 Blockade with Nivolumab in Relapsed or Refractory ...
www.nejm.org
by SM Ansell · · Cited by — D., Bjoern Chapuy, M.D., Ph.D.,. Azra H. Ligon, Ph.D., Lili Zhu, M.S., Joseph F. Grosso, Ph.D., ... › doi › pdf › NEJMoa
Network Profiles
Chapuy, Bjoern: मुफ़्त में डाउनलोड. ई-बुक पुस्तकालय. Z-Library ...
hi.art1lib.org
Thiha Aung, Bjoern Chapuy, Daniel Vogel, Dirk Wenzel, Martin Oppermann, Marlen Lahmann, Toni Weinhage, Kerstin Menck, Timo Hupfeld, Raphael Koch, ... › author
Interests
Genomic analysis unravels complexities of the most common ...
www.sciencedaily.com
30 Apr — Bjoern Chapuy, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas Kamburov, Robert A. Redd, Mike S. Lawrence, Margaretha G. M. Roemer, Amy J. › releases ›
Link between Down syndrome, leukemia uncovered -- ScienceDaily
www.sciencedaily.com
A connection between people with Down syndrome and having a heightened risk of developing acute lymphoblastic leukemia during childhood has been uncovered by...
New approach to treating B-cell acute lymphoblastic leukemia shows...
www.sciencedaily.com
A new compound that locks a disease-related protein into an inactive position stifled the growth of an aggressive form of leukemia in laboratory and animal...
Immunotherapy achieves breakthrough result in patients with Hodgkin...
www.sciencedaily.com
Eighty-seven percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission, scientists...
Business Profiles
Researchgate: Bjoern Chapuy
Boston, United States
Björn CHAPUY | Associate Professor | MD Ph.D. - ResearchGate
www.researchgate.net
› profile › Bjoern-Chapuy-2
Books & Literature
Bjoern Chapuy | University of Göttingen - Typeset.io
typeset.io
› authors › bjoern-chapuy-u616bbkvqy
JAK-STAT Signaling in Diseases - Google Books result
books.google.co.uk
Green, Michael R., Stefano Monti, Scott J. Rodig, Przemyslaw Juszczynski, Treeve Currie, Evan O'Donnell, Bjoern Chapuy, et al
Molecular Aspects of Hematologic Malignancies: Diagnostic ...
books.google.co.uk
... Bjoern Chapuy, Małgorzata Szczepaniak and Krzysztof Warzocha Abstract The vast majority of hematologic malignancies are clinically, prognostically, ...
bokus.com: Molecular Aspects of Hematologic Malignancies - Michal Witt,...
Köp Molecular Aspects of Hematologic Malignancies av Michal Witt, Malgorzata Dawidowska, Tomasz Szczepanski. Skickas inom 5-8 vardagar. Fri frakt över 199 kr....
Related Documents
Genetic resistance to JAK2 enzymatic inhibitors is overcome ...
rupress.org
by O Weigert · · Cited by 162 — Bjoern Chapuy,. Bjoern Chapuy. Departments of 1. Medical Oncology. , 2. Cancer Biology. , 3. Pediatric Oncology. , and the 4. Lurie Family Imaging Center, ... › jem › article-abstract › Genetic-resista...
Lymphoma Tumor Board May 19, 2017
research.fredhutch.org
19 May — PCNSL and PTL (primary testicular lymphoma). Bjoern Chapuy et al. Blood 2016;127: ©2016 by American Society of Hematology ... › dam › presentations
CiteSeerX — Design and Methods
citeseerx.ist.psu.edu
BibTeX @MISC{Wulf_designand, author = {Gerald G. Wulf and Anita Boehnke and Bjoern Chapuy and Bertram Glass and Bernhard Hemmerlein and Roland Schroers …
Bjoern Chapuy - Academia.edu
independent.academia.edu
Academia.edu is a place to share and follow research.
Scientific Publications
Validation of the Genetically-Defined DLBCL Subtypes and ...
www.sciencedirect.com
by B Chapuy · · Cited by 6 — ... Generation of a Parsimonious Probabilistic Classifier Bjoern Chapuy, MD PhD,1,2,3 Chip Stewart, PhD,*,4 Timothy Wood,*,4 Andrew Dunford, ... › science › article › pii
Molecular subtypes of diffuse large B cell …
pubmed.ncbi.nlm.nih.gov
Bjoern Chapuy 1 2 , Chip Stewart 3 , Andrew J Dunford 3 , Jaegil Kim 3 , Atanas Kamburov 3 , Robert A Redd 4 , Mike S Lawrence , Margaretha G M Roemer 1 , Amy J Li 6 , Marita Ziepert 7 , Annette M Staiger 8 9 , Jeremiah A Wala 3 , Matthew D Ducar 10 , Ignaty Leshchiner 3 , Ester Rheinbay 3 , Amaro Taylor-Weiner 3 , Caroline A Coughlin
Differential contribution of the mitochondrial …
www.ncbi.nlm.nih.gov
Erik Norberg, 1, 6, 7 Ana Lako, 1, 7 Pei-Hsuan Chen, 1 Illana A Stanley, 1 Feng Zhou, 1, 2 Scott B Ficarro, 1, 2 Bjoern Chapuy, 3 Linfeng Chen, 3 Scott Rodig, 4 Donghyuk Shin, 5 Dong Wook Choi, 1 Sangho Lee, 5 Margaret A Shipp, 3 Jarrod A Marto, 1, 2, 4 and Nika N Danial 1, *
BMC Cancer reviewer acknowledgement | BMC Cancer | Full Text
bmccancer.biomedcentral.com
Yu-Sun Chang. Taiwan. Yoon Soo Chang. South Korea. Wu Changjun. China. Jui-I Chao. Taiwan. Kathy Chapman. Australia. Bjoern Chapuy.
Publications
Advances in Malignant Lymphoma:
www.aacr.org
Bjoern Chapuy, University of Göttingen, Göttingen, Germany. 2:10–2:25 p.m.. Microenvironmental signatures reveal biological and clinical subtypes. › Lymphoma20_Program
Publications Authored by Bjoern Chapuy | PubFacts
www.pubfacts.com
Publications Authored by Bjoern Chapuy
SimFuse: A Novel Fusion Simulator for RNA Sequencing (RNA-Seq) Data
www.hindawi.com
The authors would like to thank Avi Spira, Evan Johnson, Luis Carvalho, and Bjoern Chapuy for constructive feedback. The authors would also ...
Molecular Aspects of Hematologic Malignancies | SpringerLink
link.springer.com
This book provides a state-of-the-art approach to the molecular basis of hematologic diseases and its translation into improved diagnostics and novel...
Reports & Statements
Twitter Posts: Ryan D Morin on Twitter: "Refreshing to hear Bjoern Chapuy ...
› morinryan › status
Twitter Posts: Lymphoma Hub on Twitter: "CONGRESS|#EHA25Virtual ...
Lymphoma Hub on Twitter: "CONGRESS|#EHA25Virtual| Bjoern Chapuy's, @uniGoettingen, presentation investigating molecular classification of aggressive Dec — Refreshing to hear Bjoern Chapuy suggest that DLBCL genetic subgroups remain a moving target and wants to see consolidation. › lymphomahub › status › morinryan › status
Molecular subtypes of diffuse large B cell lymphoma are associated...
www.nature.com
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Bjoern Chapuy,; Chip ...
Emil J Freireich Lymphoma/Myeloma Hematology Grand Roundswww3.mdanderson.org › calendar › event › Emil_J_Freireich_Lymphoma...
www3.mdanderson.org
Bjoern Chapuy, M.D., Ph.D. Instructor in Medicine. Dana-Farber Cancer Center. Presenting. “Genetic Signatures and Targetable Pathways in ...
Miscellaneous
Bjoern Chapuy | LinkedIn
www.linkedin.com
View Bjoern Chapuy's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Bjoern Chapuy discover inside ...
CXCR4 upregulation is an indicator of sensitivity to B-cell ...
www.researchpad.co
Linfeng Chen, Jing Ouyang, Kirsty Wienand, Kamil Bojarczuk, Yansheng Hao, Bjoern Chapuy, Donna Neuberg, Przemyslaw Juszczynski, Lee N. Lawton, ... › elastic_article_11022
Diffuse large B-cell lymphoma patient-derived xenograft ...
europepmc.org
by B Chapuy · · Cited by 69 — Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease. Bjoern Chapuy. Department of ... › article › pmc › pmc
FusionQuery: a novel tool for gene-specific... | Posters ...
f1000research.com
FusionQuery: a novel tool for gene-specific fusion detection. [version 1; not peer reviewed]. Yuxiang Tan1, Bjoern Chapuy, Margaret Shipp, Stefano Monti. › Browse
Immunohistochemical Detection of Increased MYC PLOS
journals.plos.org
Michael J. Kluk, Bjoern Chapuy, Papiya Sinha, Alyssa Roy, Paola Dal Cin, Donna Neuberg, Stefano Monti, Geraldine S. Pinkus, Margaret A. Shipp, ... › plosone › article › file
International Workshop on Non-Hodgkin Lymphoma - iwNHL
iwnhl.org
Bjoern Chapuy et al. • 21 Sep · Precision medicine in lymphoma 9:02. Precision medicine in lymphoma. Anas Younes et al. • 21 Sep › iwnhl highlights
Molecular subtypes of diffuse large B cell lymphoma are ...
mayoclinic.pure.elsevier.com
Bjoern Chapuy, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas Kamburov, Robert A. Redd, Mike S. Lawrence, Margaretha G.M. Roemer, Amy J. Li, ... › fingerprints
Mutations in G protein β subunits promote transformation and ...
dash.harvard.edu
by A Yoda · · Cited by 72 — Citation. Yoda, Akinori, Guillaume Adelmant, Jerome Tamburini, Bjoern Chapuy, Nobuaki Shindoh, Yuka Yoda, Oliver Weigert, et al › handle
NLRC5/MHC class I transactivator is a target for immune ...
www.pnas.org
by S Yoshihama · · Cited by 164 — Sayuri Yoshihama, Jason Roszik, Isaac Downs, +6 , Torsten B. Meissner, Saptha Vijayan, Bjoern Chapuy, Tabasum Sidiq, Margaret A. Shipp, ... › doi › abs › pnas
PD-L1 and PD-L2 Genetic Alterations Define Classical ...
ascopubs.org
by MGM Roemer · · Cited by 645 — Freeman, Philippe Armand, Bjoern Chapuy, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Azra H. Ligon, Heather H. Sun, ... › doi › JCO
Resolving the daratumumab interference with blood ...
www.sigmaaldrich.com
Resolving the daratumumab interference with blood compatibility testing. by Claudia I Chapuy, Rachel T Nicholson, Maria D Aguad, Bjoern Chapuy, ... › tech-docs › paper
Spatial Signatures Identify Immune Physician's Weekly
www.physiciansweekly.com
3 Sept — Bjoern Chapuy. Dana-Faber-Cancer Institute, Boston, Massachusetts, United States. Michael Rosenthal. Dana-Farber Cancer Institute, Boston, ... › spatial-signatures-i...
Spatial signatures identify immune escape via PD-1 as a ...
mdanderson.elsevierpure.com
by GK Griffin · · Cited by 16 — ... Alyssa Kelley, Pei Hsuan Chen, Daniel Gusenleitner, Erin Jeter, Christine Pak, Evisa Gjini, Bjoern Chapuy, Michael H. Rosenthal, Jie Xu, ... › publications › sp...
The EHA Research Roadmap: Malignant Lymphoid Diseases
researchportal.helsinki.fi
by M Dreyling · · Cited by 1 — ... Sonja Zweegman, Igor Aurer, Csaba Bodor, Birgit Burkhardt, Christian Buske, Maria Dollores Caballero, Elias Campo, Bjoern Chapuy, Andrew Davies › publications › the-eha...
Triplication of a 21q22 region contributes to B cell ...
www.scholars.northwestern.edu
by AA Lane · · Cited by 126 — Andrew A. Lane*, Bjoern Chapuy, Charles Y. Lin, Trevor Tivey, Hubo Li, Elizabeth C. Townsend, Diederik Van Bodegom, Tovah A. Day, Shuo Chieh Wu, Huiyun Liu, ... › publications
[PDF] Gene Expression Profiling in Hematologic Malignancies by ...
oa.mg
Przemyslaw Juszczynski,Bjoern Chapuy,Małgorzata Szczepaniak,Krzysztof Warzocha ... Abstract: The vast majority of hematologic malignancies are clinically, ... › work
Defeating Diffuse, Double-Hit and Dogged Non-Hodgkin ...
ash.confex.com
11 Dec — Kieron Dunleavy, MD, George Washington University Cancer Center , Bjoern Chapuy, MD, University of Göttingen and Reem Karmali, MD, MSc, ... › webprogram › Session20397
sorted by relevance / date